Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

SAT0389 Long-Term Improvements in Workplace and Household Productivity and Social Participation over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

10.1136/annrheumdis-2016-eular.3235 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 809.1-809

Author(s):

D. van der Heijde ◽

J. Braun ◽

M. Rudwaleit ◽

R. Landewé ◽

O. Purcaru ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Social Participation ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

Value in Health ◽

10.1016/j.jval.2014.08.2653 ◽

2014 ◽

Vol 17 (7) ◽

pp. A387

Author(s):

der Heijde D. van ◽

J. Braun ◽

M. Rudwaleit ◽

O. Purcaru ◽

A. Kavanaugh

Keyword(s):

Ankylosing Spondylitis ◽

Social Participation ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

OP0107 Improvements in Work and Household Productivity after 24 Weeks of Certolizumab Pegol in Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of Rapid-Axspa Study

10.1136/annrheumdis-2013-eular.312 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A87.1-A87

Author(s):

D. van der Heijde ◽

J. Braun ◽

M. Rudwaleit ◽

O. Purcaru ◽

A. Kavanaugh

Keyword(s):

Ankylosing Spondylitis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study

Value in Health ◽

10.1016/j.jval.2014.08.2643 ◽

2014 ◽

Vol 17 (7) ◽

pp. A385-A386

Author(s):

J. Sieper ◽

A. Kivitz ◽

A. van Tubergen ◽

A. Deodhar ◽

B. Szegvari ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Patient Reported Outcomes ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Patient Reported ◽

Term Maintenance

PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study

Value in Health ◽

10.1016/j.jval.2012.08.1422 ◽

2012 ◽

Vol 15 (7) ◽

pp. A451-A452

Author(s):

V. Strand ◽

O. Purcaru ◽

R. Van vollenhoven ◽

E. Choy ◽

R. Fleischmann

Keyword(s):

Rheumatoid Arthritis ◽

Social Participation ◽

Certolizumab Pegol ◽

Extension Study ◽

Open Label ◽

Open Label Extension ◽

SAT0351 Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Outcomes of the Rapid-Axspa Trial

10.1136/annrheumdis-2014-eular.1636 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 719.3-720

Author(s):

J. Sieper ◽

M. Rudwaleit ◽

D. van der Heijde ◽

W. Maksymowych ◽

M. Dougados ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Safety And Efficacy

Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 4-Year Outcomes from the Rapid-Axspa Study

Value in Health ◽

10.1016/j.jval.2016.09.1430 ◽

2016 ◽

Vol 19 (7) ◽

pp. A595

Author(s):

J Sieper ◽

A Kivitz ◽

A van Tubergen ◽

A Deodhar ◽

K Harris ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Patient Reported Outcomes ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Patient Reported

FRI0204 Long-term benefits of 4-weekly certolizumab pegol monotherapy and combination therapy on household productivity and social participation in rheumatoid arthritis: 5-year results from an open-label extension study

10.1136/annrheumdis-2013-eular.1331 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A441.2-A442 ◽

Cited By ~ 1

Author(s):

V. Strand ◽

O. Purcaru ◽

R. van Vollenhoven ◽

E. Choy ◽

R. Fleischmann

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Social Participation ◽

Certolizumab Pegol ◽

Extension Study ◽

Open Label ◽

Open Label Extension ◽

Continued Improvements in Workplace and Household Productivity with Certolizumab Pegol Treatment in Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 48-Week Results from the Rapid-axSpA Study

Value in Health ◽

10.1016/j.jval.2013.08.1530 ◽

2013 ◽

Vol 16 (7) ◽

pp. A570

Author(s):

D. van der Heijde ◽

J. Braun ◽

M. Rudwaleit ◽

O. Purcaru ◽

A. Kavanaugh

Keyword(s):

Ankylosing Spondylitis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 48-Week Results of the Rapid-axSpA Study

Value in Health ◽

10.1016/j.jval.2013.08.1523 ◽

2013 ◽

Vol 16 (7) ◽

pp. A569 ◽

Cited By ~ 1

Author(s):

J Sieper ◽

A. Kivitz ◽

A. van Tubergen ◽

A. Deodhar ◽

G. Coteur ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Patient Reported Outcomes ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Patient Reported ◽

Term Maintenance